VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U7189AA: VAERS reports

25 VAERS reports list lot U7189AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2022-04-26 and 2023-12-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
4%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological826%
Musculoskeletal826%
General / Systemic (non-local)826%
Cardiac / Cardiovascular26%
Respiratory26%
Injection-site / Local reaction26%
Allergic / Anaphylactic13%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York3
Virginia2
Wisconsin2
Georgia2
Oregon2
North Carolina2
Michigan1
Missouri1
Maine1
Texas1
Alabama1
Pennsylvania1

Reports by month received

2022-041
2022-052
2022-083
2022-091
2022-101
2022-112
2022-121
2023-021
2023-031
2023-041
2023-061
2023-082
2023-106
2023-111
2023-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.